Washington D.C.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Huntington's disease3 trials

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Completed2 trials
• Terminated1 trial

Lead sponsor

• Supernus Pharmaceuticals, Inc.3 trials

Closed trials

• Terminated

  A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease

  NCT05655520· Phase 3· Supernus Pharmaceuticals, Inc.· Source

• Completed

  28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

  NCT05358821· Phase 2· Supernus Pharmaceuticals, Inc.· Source

• Completed

  A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

  NCT05107128· Phase 2· Supernus Pharmaceuticals, Inc.· Source